RESULTS: The total admissions (excluding readmissions) were 2219 patients. There was only 190 candidates for PPSV23, of whom 163 patients received the PPSV23 vaccine and 27 candidate declined the vaccination. The rest of admissions either had already been vaccinated elsewhere or did not qualify. Of the 163 patients, there was 49% age group 19-64 years old, and 51% age of 65 years or older. All patients who had received the PPSV23 were qualified to one or more of the eligibility criteria as per ACIP recommendations. We applied the ACIP eligibility criteria for PCV13 on the patients who received the PPSV23 and we found 48 patients (29%) are actually also candiadates for PCV13 from the age group 19-64, in addition to 83 patients who were 65 years or older. The majority of those who were qualified from the age group 19-64 yrs old were under the following subcategories: generalized malignancy (29 patients), followed by five patients with immunodeficiency conditions, three patients with chronic renal failure (CRF), two patients with asplenia, two patients with solid organ transplant and the rest under other PCV13 indications.